However, there are many unknowns, and to the best of our knowledge, this is the first study to investigate the effects of the intranasal administration of CRHR2 agonist on the development of PTSD-like symptoms in an animal model. This evidence concerns the gene CRHR2 and post-traumatic stress disorder.